8111:TSEGoldwin Inc. Analysis
Data as of 2026-06-20 - not real-time
¥2,190.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Goldwin Inc. trades around ¥2,190, comfortably above its 20‑day SMA of ¥2,129.8 but still below the 200‑day SMA of ¥2,469.6, signaling a short‑term bounce within a longer‑term downtrend. The RSI sits at 55, indicating neutral momentum, while the MACD histogram is positive (+13.9), suggesting bullish pressure that could test the resistance at ¥2,219. Volatility is elevated at 31.5 % over the past 30 days, yet the beta is exceptionally low (0.05), implying limited systematic risk.
Fundamentally, the company boasts a solid 19.9 % ROE, healthy gross margin of 53 %, and a strong cash position of ¥58.5 bn against modest debt of ¥4.5 bn. The dividend yield of 3.19 % with a payout ratio near 31 % appears sustainable, and a forward PE of 3.6× points to significant value relative to earnings growth. However, the DCF‑derived fair value of roughly ¥948 suggests the market price is considerably above intrinsic estimates, indicating potential overvaluation.
Given the mixed technical outlook, strong fundamentals, and attractive dividend, investors may consider a cautious stance: hold the stock in the near term while evaluating price action around support at ¥2,040, and contemplate buying on pull‑backs for medium‑ to long‑term exposure to the company’s earnings growth and cash‑generating capacity.
Fundamentally, the company boasts a solid 19.9 % ROE, healthy gross margin of 53 %, and a strong cash position of ¥58.5 bn against modest debt of ¥4.5 bn. The dividend yield of 3.19 % with a payout ratio near 31 % appears sustainable, and a forward PE of 3.6× points to significant value relative to earnings growth. However, the DCF‑derived fair value of roughly ¥948 suggests the market price is considerably above intrinsic estimates, indicating potential overvaluation.
Given the mixed technical outlook, strong fundamentals, and attractive dividend, investors may consider a cautious stance: hold the stock in the near term while evaluating price action around support at ¥2,040, and contemplate buying on pull‑backs for medium‑ to long‑term exposure to the company’s earnings growth and cash‑generating capacity.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with a bearish long‑term trend
- Bullish MACD histogram but limited upside
- Stable trading volume reducing short‑term liquidity concerns
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong cash generation and low leverage
- Forward PE of 3.6× indicating deep value
- Sustainable dividend enhancing total return
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Consistent revenue growth and solid operating margins
- Robust brand portfolio and partnership network
- Dividend sustainability supporting shareholder yield
Key Metrics & Analysis
Financial Health
Revenue Growth7.30%
Profit Margin17.52%
P/E Ratio12.5
ROE19.99%
ROA10.13%
Debt/Equity3.48
P/B Ratio2.3
Op. Cash Flow¥26.3B
Free Cash Flow¥4.2B
Technical Analysis
TrendBearish
RSI55.4
Support¥2,040.00
Resistance¥2,219.00
MA 20¥2,129.80
MA 50¥2,183.45
MA 200¥2,469.59
MACDBullish
VolumeStable
Fear & Greed Index91.46
Valuation
Fair Value¥947.91
Target Price¥3,150.00
Upside/Downside43.84%
GradeOvervalued
TypeBlend
Dividend Yield3.19%
Risk Assessment
Beta0.05
Volatility31.53%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.